CIK 0001661998 · Non-accelerated filer<br>Smaller reporting company
Q32 Bio Inc.
Sign in to watch- Ticker
- QTTB
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 473468154
- Phone
- 781-999-0232
- Business address
- 830 WINTER STREET, WALTHAM, MA, 02451
- Former names
- Q32 Bio Inc., Homology Medicines, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $320,396
- in 6 filings
Net −$320,396. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-06-14 | Poulton Jeffrey V. Director | Grant or award · Option (Right to Buy) | +23,000 | 23,000 | ||
| 2023-06-14 | REICIN ALISE Director | Grant or award · Option (Right to Buy) | +23,000 | 23,000 | ||
| 2023-03-02 | Alloway Paul See Remarks | Sale | −10,965 | $1.45 | $16K | 16,706 |
| 2023-02-23 | Alloway Paul See Remarks | Grant or award · Employee Stock Option (Right to Buy) | +164,000 | 164,000 | ||
| 2023-02-23 | Alloway Paul See Remarks | Grant or award · Restricted Stock Units | +27,000 | 27,000 | ||
| 2018-04-02 | Novartis Institutes for BioMedical Research, Inc. 10% owner | Conversion | +1,979,226 | 1,979,226 | ||
| 2018-04-02 | Novartis Institutes for BioMedical Research, Inc. 10% owner | Conversion · Series B Preferred Stock | −1,979,226 | 0 |
Page 11 of 11 · 207 trades